Erythrocytosis after renal transplantation represents an abnormality of insulin-like growth factor-I and its binding proteins

Transplantation

Volumn 66, Issue 8, 1998, Pages 1053-1058

  Brox, Alan G ^a   Mangel, Joy ^b   Hanley, James A ^b   Louis, Gilles S T ^c   Mongrain, Sylvie ^c   Gagnon, Raymonde F ^d  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c NOTRE DAME HOSPITAL   (Canada)

^d MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; ERYTHROCYTOSIS; ERYTHROPOIESIS; FEMALE; HUMAN; KIDNEY TRANSPLANTATION; MALE; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

ADULT; AGED; ERYTHROPOIETIN; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; KIDNEY TRANSPLANTATION; MALE; MEDICAL RECORDS; MIDDLE AGED; POLYCYTHEMIA; POSTOPERATIVE COMPLICATIONS;

EID: 0032573038     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199810270-00015     Document Type: Article

References (36)

1. Claustres M, Chatelin P, Sultan C. Insulin-like growth factor stimulates erythroid colony formation in vitro. J Clin Endocrinol Metab 1987; 65: 78.
2. Merchav S, Tatarsky I, Hochberg Z. Enhancement of human granulopoiesis in vitro by biosynthetic insulin-like growth factor I/somatomedin C and human growth hormone. J Clin Invest 1988; 81: 791.
3. Aron DC. Insulin-like growth factor I and erythropoiesis. Biofactors 1992; 3: 211.
4. Boyer SH, Bishop TR, Rogers OC, Noyes AN, Freiin LP, Hobbs S. Roles of erythropoietin, insulin-like growth factor I, and unidentified serum factors in promoting maturation of purified murine erythroid colony-forming units. Blood 1992; 80: 2503.
5. Sawada K, Krantz SB, Dessypris EN, Koury ST, Sawyer ST. Human colony-forming units-erythroid do not require accessory cells, but do require direct interaction with insulin-like growth factor I and/or insulin for erythroid development. J Clin Invest 1989; 83: 1701.
6. Dainiak N, Kreczko S, Cohen A, Panell R, Lawler J. Primary human marrow cultures for erythroid bursts in a serum-substituted system. Exp Hematol 1985; 13: 1073.
7. Dainiak N. Role of defined and undefined serum additives to hematopoietic stem cell culture. In: Cronkite, EP, Dainiak, N, McCafferty RP, eds, Hematopoietic stem cell physiology. New York: Liss, 1985; 59.
8. Sanders M, Sorba S, Dainiak N. Insulin-like growth factors stimulate erythropoiesis in serum-substituted umbilical cord blood cultures. Exp Hematol 1993; 21: 25.
9. Brox AG, Zhang F, Guyda H, Gagnon RF. Subtherapeutic erythropoietin and insulin-like growth factor-I correct the anemia of chronic renal failure in the mouse. Kidney Int 1996; 50: 937.
10. Brox AG, Congote LF, Fafard J, Fauser AA. Identification and characterization of an 8-kd peptide stimulating late erythropoiesis. Exp Hematol 1989; 17: 769.
11. Congote LF, Brox AG, Lin FK, Lu HS, Fauser AA. The N-terminal sequence of the major erythropoietic factor of an anephric patient is identical to insulin-like growth factor 1. J Clin Endocrinol Metab 1991; 72: 727.
12. Zhang F, Gagnon RF, Richards GK, Brox AG. Anemia of chronic renal failure: characterization in the mouse and correction with human recombinant erythropoietin. Nephron 1996; 72: 654.
13. Zhang F, Laneuville P, Morin B, Gagnon RF, Brox AG. Effect of chronic renal failure on the expression of erythropoietin message in a murine model. Exp Hematol 1996; 24: 1469.
14. Brox AG, Band C, Morin B, Gagnon RF. Erythropoietin down-regulates insulin-like growth factor binding protein I levels in the liver of mice with chronic renal failure [Abstract]. Blood 1996; 88: 3152.
15. Mirza AM, Correa PN, Axelrad AA. Increased basal and induced tyrosine phosphorylation of the insulin-like growth factor-1 receptor beta subunit in circulating mononuclear cells of patients with polycythemia vera. Blood 1995; 86: 877.
16. Cottea PN, Eskinazi D, Axelrad AA. Circulating erythroid progenitors in polycythemia vera are hypersensitive to insulin-like growth factor-1 in vitro: studies in an improved serum-free medium. Blood 1994; 83: 99.
17. Mirza AM, Ezzat S, Axelrad AA. Insulin-like growth factor binding protein-1 is elevated in patients with polycythemia vera and stimulates erythroid burst formation in vitro. Blood 1997; 89: 1862.
18. Gaston RS, Julian BA, Curtis JJ. Post transplant erythrocytosis: an enigma revisited. Am J Kidney Dis 1994; 24: 1.
19. Perazella M, McPhedran P, Kliger A, Lorber M, Levy E, Bia MJ. Enalapril treatment of post transplant erythrocytosis: efficacy independent of circulating erythropoietin levels. Am J Kidney Dis 1995; 26: 495.
20. Qunibi VY, Barri Y, Devol E, Al-Furayh O, Sheth K, Taher S. Factors predictive of post transplant erythrocytosis. Kidney Int 1991; 40:1153.
21. Wickre CG, Norman DJ, Bennison A, Barry JM, Bennett WM. Postrenal transplant erythrocytosis: a review of 53 patients. Kidney Int 1983; 23:731.
22. Sumrani NB, Daskalakis, P, Miles AM. Erythrocytosis after renal transplantation: a prospective analysis. ASAIO J 1993; 39: 51.
23. Dagher F J, Ramos E, Erslev AJ, Alongi SV, Karmi SA, Caro J. Are the native kidneys responsible for erythrocytosis in renal allorecipients? Transplantation 1979; 28: 496.
24. Aeberhard J-M, Schneider P-A, Vallotton MB, Kurtz A, Leski M. Multiple site estimates of erythropoietin and renin in polycythemic kidney transplant patients. Transplantation 1990; 50: 613.
25. Garvin PJ, Reese JC, Lindsey L, Aridge DL, Domoto DT, Ballal S. Bilateral nephrectomy for post transplant erythrocytosis: indications and results. Clin Transplant 1991; 5:313.
26. Thevenod F, Radtke HW, Grutzmacher P. Deficient feedback regulation of erythropoiesis in kidney transplant patients with polycythemia. Kidney Int 1983; 24: 227.
27. Sauron C, Berthoux P, Berthoux F. New insights and treatment in post transplant polycythemia (erythrocytosis) of renal recipients. Transplant Proc 1993; 25: 1032.
28. Danovitch GM, Jamgotchian NJ, Eggena PH. Amelioration of renal transplant erythrocytosis with enalapril: studies on mechanism. J Am Soc Nephrol 1993; 4: 930 (abstract).
29. Perazella M, Kliger A, Levy E, McPhedran P, Lorber M, Bia MJ. Enalapril treatment of post transplant erythrocytosis: mechanism of action [Abstract]. J Am Soc Nephrol 1993; 4: 954.
30. Morrone LF, Di Paolo S, Logoluso F. Interference of angiotensin-converting enzyme inhibitors on erythropoiesis in kidney transplant recipients. Transplantation 1997; 64: 913.
31. Hussenet F, Dousset B, Gervais P. Serum insulin-like growth factor-I and binding proteins (IGF BP-1 and IGF BP-3) concentrations after renal transplantation in adults. Transplant Proc 1996; 28: 3615.
32. Drop SLS, Schuller AGP, Lindenbergh-Kortleve DJ, Groffen C, Brinkman A, Zwarthoff EC. Structural aspects of the IGFBP family. Growth Regul 1992; 2: 69.
33. Rechler MM, Brown AL. Insulin-like growth factor binding proteins: Gene structure and expression. Growth Regul 1992; 2: 55.
34. Clemmons DR. IGF binding proteins: regulation of cellular actions. Growth Regul 1992; 2: 80.
35. Lee PDK, Conover CA, Powell DR. Regulation and function of insulin-like growth factor-binding protein-1. Proc Soc Exp Biol Med 1993; 204: 4.
36. Baxter RC, Martin JL. Binding proteins for the insulin-like growth factors: structure, regulation and function. Prog Growth Factor Res 1989; 1: 49.